These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 22223182)
1. Does dialysis modality influence the oxidative stress of uremic patients? Capusa C; Stoian I; Rus E; Lixandru D; Barbulescu C; Mircescu G Kidney Blood Press Res; 2012; 35(4):220-5. PubMed ID: 22223182 [TBL] [Abstract][Full Text] [Related]
2. Global assessment of serum antioxidant status in hemodialysis patients. Mircescu G; Capuşă C; Stoian I; Vârgolici B; Barbulescu C; Ursea N J Nephrol; 2005; 18(5):599-605. PubMed ID: 16299688 [TBL] [Abstract][Full Text] [Related]
3. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Sardenberg C; Suassuna P; Andreoli MC; Watanabe R; Dalboni MA; Manfredi SR; dos Santos OP; Kallas EG; Draibe SA; Cendoroglo M Nephrol Dial Transplant; 2006 Jan; 21(1):160-5. PubMed ID: 16155068 [TBL] [Abstract][Full Text] [Related]
4. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities. Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577 [TBL] [Abstract][Full Text] [Related]
5. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis. Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992 [TBL] [Abstract][Full Text] [Related]
6. Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients. Zhou Q; Wu S; Jiang J; Tian J; Chen J; Yu X; Chen P; Mei C; Xiong F; Shi W; Zhou W; Liu X; Sun S; Xie DI; Liu J; Xu X; Liang M; Hou F Nephrology (Carlton); 2012 Sep; 17(7):642-9. PubMed ID: 22738256 [TBL] [Abstract][Full Text] [Related]
7. Effect of hemodialysis and peritoneal dialysis on redox status in chronic renal failure patients: a comparative study. Mekki K; Taleb W; Bouzidi N; Kaddous A; Bouchenak M Lipids Health Dis; 2010 Sep; 9():93. PubMed ID: 20815897 [TBL] [Abstract][Full Text] [Related]
8. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease. Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871 [TBL] [Abstract][Full Text] [Related]
9. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments. Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086 [TBL] [Abstract][Full Text] [Related]
11. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis. Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168 [TBL] [Abstract][Full Text] [Related]
12. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes. Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573 [TBL] [Abstract][Full Text] [Related]
13. Protein oxidative stress and dyslipidemia in dialysis patients. Marques de Mattos A; Marino LV; Ovidio PP; Jordão AA; Almeida CC; Chiarello PG Ther Apher Dial; 2012 Feb; 16(1):68-74. PubMed ID: 22248198 [TBL] [Abstract][Full Text] [Related]
14. Impairment of glutathione biosynthetic pathway in uraemia and dialysis. Alhamdani MS Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350 [TBL] [Abstract][Full Text] [Related]
15. Effects of peritoneal-and hemodialysis on levels of plasma protein and lipid oxidation markers in diabetic patients. Sozer V; Korkmaz Guntas G; Konukoglu D; Dervisoglu E; Gelisgen R; Tabak O; Kalender B; Uzun H Minerva Med; 2013 Feb; 104(1):75-84. PubMed ID: 23392540 [TBL] [Abstract][Full Text] [Related]
16. Accumulation of vitamin E metabolites in the blood of renal failure patients. Galli F; Floridi AG; Floridi A; Buoncristiani U Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960 [TBL] [Abstract][Full Text] [Related]
17. Correlation of oxidative stress biomarkers and peritoneal urea clearance with mitochondrial DNA copy number in continuous ambulatory peritoneal dialysis patients. Chen JB; Lin TK; Liou CW; Liao SC; Lee LC; Wang PW; Tiao MM Am J Nephrol; 2008; 28(5):853-9. PubMed ID: 18547945 [TBL] [Abstract][Full Text] [Related]
18. Effect of hemodialysis on total antioxidant status of chronic renal failure patients in government hospitals in Lagos Nigeria. Ajala MO; Ogunro PS; Odun A Niger J Clin Pract; 2011; 14(2):154-8. PubMed ID: 21860130 [TBL] [Abstract][Full Text] [Related]
19. Does oxidative stress affect the activity of the sodium-proton exchanger? Bober J; Kedzierska K; Kwiatkowska E; Stachowska E; Gołembiewska E; Mazur O; Staniewicz Z; Ciechanowski K; Chlubek D Ann Acad Med Stetin; 2010; 56(3):5-12. PubMed ID: 22053621 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis]. Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]